Abstract

The outcomes for patients implanted with left ventricular assist devices are continuously improving as demonstrated by recent studies. However, options for durable biventricular support remain limited with the Syncardia total artificial heart being the only FDA approved device available. BiVACOR is a future device featuring a magnetically levitated impeller that supports pulsatile flow. This study discusses the pump implant process in a series of acute large animals.